Test Compendium

Test Compendium is your definitive resource for detailed information on a wide array of diagnostic tests. Each entry in our compendium is meticulously cataloged to aid healthcare providers in selecting and interpreting the right tests for their patients.

Yes

Displaying 226 - 250 of 352

PLAP

Immunohistochemistry (IHC)

PLAP Alternative Name Placental Alkaline Phosphatase Methodology Immunohistochemistry (IHC) Test Description Probes/Genes PLAP IHC Disease Germ cell neoplasms, seminoma, dysgerminoma, and germinoma of


PMS2

Immunohistochemistry (IHC)

PMS2 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes MSI Disease Colorectal cancersPMS2 is a component of the DNA mismatch repair system/ The PMS2 gene (on chromosome 7) encodes an


PR

Immunohistochemistry (IHC)

PR Alternative Name Progesterone Receptor, PgR Methodology Immunohistochemistry (IHC) Test Description Probes/Genes PR IHC Disease Breast cancerPR belongs to the superfamily of steroid hormone receptors,


PSA

Immunohistochemistry (IHC)

PSA Alternative Name Prostate Specific Antigen Methodology Immunohistochemistry (IHC) Test Description Probes/Genes PSA IHC Disease Prostate cancerMarker of glandular epithelium in normal and neoplastic


PSAP

Immunohistochemistry (IHC)

PSAP Alternative Name Prostate Specific Acid Phosphatase Methodology Immunohistochemistry (IHC) Test Description Probes/Genes PSAP IHC Disease Differentiates between prostatic and urothelial carcinomas/Differentiates


PSMA

Immunohistochemistry (IHC)

PSMA Alternative Name Prostate Specific Membrane Antigen Methodology Immunohistochemistry (IHC) Test Description Probes/Genes PSMA IHC Disease Metastatic prostate carcinomaType II transmembrane glycoprotein


RCC

Immunohistochemistry (IHC)

RCC Alternative Name Renal Cell Carcinoma 1 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes RCC IHC Disease Renal cell carcinomaAnti renal cell carcinoma (RCC) antibodies detect a


Reticulin

Special Stains

Reticulin Alternative Name Reticular Nuclear Fast Red Stain Methodology Special Stains Test Description Probes/Genes RETIC SS Disease Outlines architecture of liver and spleen,hemangiopericytoma, vascular


S-100

Immunohistochemistry (IHC)

S-100 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes S100 IHC Disease Marker of schwann cells and melanocyte, nerve sheath tumors, melanoma, and Langerhans cell histiocytosisFamily


SMMS-1

Immunohistochemistry (IHC)

SMMS-1 Alternative Name Smooth Muscle Myosin, Heavy Chain, SMMHC Methodology Immunohistochemistry (IHC) Test Description Probes/Genes SMMS IHC Disease Distinguish benign breast lesions and carcinoma in


SOX-10

Immunohistochemistry (IHC)

SOX-10 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes SOX-10 IHC Disease Melanoma marker, soft tissue tumors of neural crest originTranscription factor known to be crucial in the


SOX11

Immunohistochemistry (IHC)

SOX11 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes SOX11 IHC Disease Mantle cell lymphomaSOX11 is a transcription factor that is normally expressed in the fetal brain and has also


STAT6

Immunohistochemistry (IHC)

STAT6 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes stat6 IHC Disease Distinction of solitary fibrous tumorSignal transducer and activator of transcription (STAT) 6/Member of STAT


Synaptophysin

Immunohistochemistry (IHC)

Synaptophysin Methodology Immunohistochemistry (IHC) Test Description Probes/Genes SYNAPT IHC Disease Identification of neuronal tumors and tumors with neuroendocrine differentiationA protein (38 kD),


TdT

Immunohistochemistry (IHC)

TdT Methodology Immunohistochemistry (IHC) Test Description Probes/Genes TDT IHC Disease Differentiating precursor lymphoid neoplasms, from other small blue cell tumors. Identifying clusters of thymocytes


Thrombomodulin (TM)

Immunohistochemistry (IHC)

Thrombomodulin (TM) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes THROM IHC Disease Mesothelioma, Squamous Cell Carcinoma, Urothelial Carcinoma.Also called CD141. Thrombomodulin


Thyroglobulin (TGB)

Immunohistochemistry (IHC)

Thyroglobulin (TGB) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes THYRO IHC Disease Classification of thyroid carcinomaLarge glycoprotein (MW 670K) produced by thyroid follicular


TIA-1

Immunohistochemistry (IHC)

TIA-1 Alternative Name T-cell Intracytoplasmic Antigen Methodology Immunohistochemistry (IHC) Test Description Probes/Genes TIA1 IHC Disease Neoplasms of cytotoxic T cells or natural killer cellsTIA-I


TRAP

Immunohistochemistry (IHC)

TRAP Alternative Name Tartrate Resistant Acid Phosphatase Methodology Immunohistochemistry (IHC) Test Description Probes/Genes TRAP IHC Disease Hairy cell leukemia, mantle cell lymphoma, splenic marginal


Trichrome

Special Stains

Trichrome Methodology Special Stains Test Description Probes/Genes TRI SS Disease Collagen and smooth muscle in tumors, cirrhosisStains collagen blue


TTF-1

Immunohistochemistry (IHC)

TTF-1 Alternative Name Thyroid Transcription Factor Methodology Immunohistochemistry (IHC) Test Description Probes/Genes TTF1 IHC Disease Distinguish primary and metastatic lung carcinoma from non lung


Tyrosinase

Immunohistochemistry (IHC)


Uroplakin II

Immunohistochemistry (IHC)

Uroplakin II Methodology Immunohistochemistry (IHC) Test Description Probes/Genes UROPII IHC Disease Urothelial lesions/Ovarian Brenner tumorTransmembrane protein expressed by urothelial lining cells (umbrella


Uroplakin III

Immunohistochemistry (IHC)

Uroplakin III Methodology Immunohistochemistry (IHC) Test Description Probes/Genes UROPIII IHC Disease Urothelial lesions/Ovarian Brenner tumorTransmembrane protein expressed by urothelial lining cells


Vimentin

Immunohistochemistry (IHC)

Vimentin Methodology Immunohistochemistry (IHC) Test Description Probes/Genes VIMENT IHC Disease fibrosarcomas, liposarcomas, malignant fibrous histocytomas, angiosarcomas, chondrosarcomas and lymphomasVimentin


Discover more.

A Model Experience

With core values rooted in service and integrity, our leadership team sets the bar high.

We consistently strive to set the model for exactly how a reference laboratory should engage with both physicians and patients.

Accredited and Certified

siParadigm is accredited by CLIA (Clinical Laboratory Improvement Amendments) and certified by CAP (College of American Pathologists).

We also hold select state licensure where required.